RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gland Pharma Stock

Gland Pharma Equity 2025

Gland Pharma Equity

0 INR

Ticker

GLAND.NS

ISIN

INE068V01023

In 2025, Gland Pharma's equity was 0 INR, a -100% increase from the 79.59 B INR equity in the previous year.

Gland Pharma Aktienanalyse

What does Gland Pharma do?

Gland Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Gland Pharma's Equity

Gland Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Gland Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Gland Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Gland Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Gland Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Gland Pharma stock

What is the equity of Gland Pharma this year?

Gland Pharma has equity of 0 INR this year.

What was the equity of Gland Pharma compared to the previous year?

The equity of Gland Pharma has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of Gland Pharma?

A high equity is advantageous for investors of Gland Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Gland Pharma?

A low equity can be a risk for investors of Gland Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Gland Pharma affect the company?

An increase in equity of Gland Pharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Gland Pharma affect the company?

A reduction in equity of Gland Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Gland Pharma?

Some factors that can affect the equity of Gland Pharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Gland Pharma so important for investors?

The equity of Gland Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Gland Pharma take to change the equity?

To change equity, Gland Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Gland Pharma pay?

Over the past 12 months, Gland Pharma paid a dividend of 20 INR . This corresponds to a dividend yield of about 1.03 %. For the coming 12 months, Gland Pharma is expected to pay a dividend of 20 INR.

What is the dividend yield of Gland Pharma?

The current dividend yield of Gland Pharma is 1.03 %.

When does Gland Pharma pay dividends?

Gland Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gland Pharma?

Gland Pharma paid dividends every year for the past 0 years.

What is the dividend of Gland Pharma?

For the upcoming 12 months, dividends amounting to 20 INR are expected. This corresponds to a dividend yield of 1.03 %.

In which sector is Gland Pharma located?

Gland Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gland Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gland Pharma from 9/27/2025 amounting to 18 INR, you needed to have the stock in your portfolio before the ex-date on 8/14/2025.

When did Gland Pharma pay the last dividend?

The last dividend was paid out on 9/27/2025.

What was the dividend of Gland Pharma in the year 2024?

In the year 2024, Gland Pharma distributed 0 INR as dividends.

In which currency does Gland Pharma pay out the dividend?

The dividends of Gland Pharma are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gland Pharma

Our stock analysis for Gland Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gland Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.